18 pages matching price reductions in this book
Results 1-3 of 18
What people are saying - Write a review
We haven't found any reviews in the usual places.
A Market Perspective on Recent Developments in the TRIPS and
The Economics of TRIPS Options for Access to Medicines
15 other sections not shown
access to essential access to medicines AIDS anti-retroviral ARVs benefits Brazil Brazilian capita cent ceutical competition compulsory licensing consumers developing countries developing world differential pricing diseases distribution domestic drug prices economic effective ensure equity-pricing essential drugs essential medicines export firms funding GlaxoSmithKline global health services health system HIV-AIDS impact implemented incentives income increase India infections initiatives innovation intellectual property protection intellectual property rights investment issue ivermectin lower prices manufacturers marginal cost Maskus MECTIZAN Merck million Ministry of Health negotiation onchocerciasis Oxfam parallel imports parallel trade patent protection patent-holder patented drugs pharma pharmaceutical companies pharmaceutical industry pharmaceutical market pharmaceutical products poor countries price controls price discrimination price reductions profits programmes public health purchasing reduce sector South Africa therapy treatment TRIPS Agreement Uganda UNAIDS United vaccines Watal World Bank World Health Organization World Trade Organization